Autopsy report · NCT01730157
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
Cause of deathOther
“Research Cancelled”
Life of this trial
- Registered 1 month before it started.
- Ran for about 3 years 2 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Early Phase 1
- Sponsor
- Case Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Ciliary Body and Choroid Melanoma, Medium/Large Size; Ciliary Body and Choroid Melanoma, Small Size; Extraocular Extension Melanoma; Iris Melanoma; Liver Metastases; Metastatic Intraocular Melanoma
- Interventions
- ipilimumab; yttrium Y 90 glass microspheres; laboratory biomarker analysis
- Participants
- 6
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.